Canada Life
RPTX

Canada Life’s Repare Therapeutics RPTX Stock Holding History

Canada Life’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-676
Closed -$8K – 2210
2023
Q3 		$8K Hold
676
– – ﹤0.01% 2220
2023
Q2 		$7K Hold
676
– – ﹤0.01% 2248
2023
Q1 		$7K Hold
676
– – ﹤0.01% 2306
2022
Q4 		$10K Hold
676
– – ﹤0.01% 2326
2022
Q3 		$8K Hold
676
– – ﹤0.01% 2363
2022
Q2 		$9K Hold
676
– – ﹤0.01% 2378
2022
Q1 		$10K Hold
676
– – ﹤0.01% 2436
2021
Q4 		$14K Hold
676
– – ﹤0.01% 2423
2021
Q3 		$18K Hold
676
– – ﹤0.01% 2453
2021
Q2 		$21K Hold
676
– – ﹤0.01% 2477
2021
Q1 		$20K Hold
676
– – ﹤0.01% 2508
2020
Q4 		$23K Buy
+676
New +$20.2K ﹤0.01% 2515

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Canada Life's RPTX Position: Q4 2023 in Review

Canada Life sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 676 shares — an estimated $8K sold.

Canada Life first reported a position in RPTX in Q4 2020 and held it in 12 quarters. The position peaked at $23K in Q4 2020. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • Canada Life reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Canada Life sold 676 Repare Therapeutics shares in Q4 2023, an estimated $8K.
  • Canada Life first reported a position in Repare Therapeutics in Q4 2020 and held it in 12 quarters.
  • Canada Life's Repare Therapeutics position peaked at $23K in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.